BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7655105)

  • 21. Discoid lesions and smoking history are negative predictors of disease activity remission in cutaneous lupus erythematosus.
    Florez-Pollack S; Rizvi SK; Hynan LS; Chong BF
    J Am Acad Dermatol; 2022 Nov; 87(5):1135-1137. PubMed ID: 35151758
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinicopathological and Immunological Profile of Patients with Cutaneous Manifestations and their Relationship with Organ Involvement in Systemic Lupus Erythematosus Attending a Tertiary Care Center of Eastern India.
    Ghosh AP; Nag F; Biswas S; Rao R; De A
    Indian J Dermatol; 2020; 65(1):22-28. PubMed ID: 32029935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in disease activity needed for meaningful change in cutaneous lupus by patient characteristic: A retrospective analysis of a longitudinal database.
    Kleitsch J; Pandya R; Chakka S; Yan D; Lim D; Diaz D; Feng R; Werth VP
    J Am Acad Dermatol; 2024 Feb; 90(2):406-408. PubMed ID: 37806526
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical epidemiology of tumid lupus erythematosus: A retrospective review of 179 patients.
    Sanchez-Melendez S; Malik R; Kanwar R; Yang K; Nambudiri VE
    J Am Acad Dermatol; 2024 Jan; 90(1):202-204. PubMed ID: 37769903
    [No Abstract]   [Full Text] [Related]  

  • 25. The prevalence of oral mucosal lesions and related factors in systemic lupus erythematosus patients.
    Kudsi M; Nahas LD; Alsawah R; Hamsho A; Omar A
    Arthritis Res Ther; 2021 Sep; 23(1):229. PubMed ID: 34479636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of annular polycyclic, morpheaform and atrophic lesions in neonatal lupus erythematosus.
    Kulkarni S; Adya KA; Janagond AB; Inamadar A
    BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36316053
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of oral manifestations in patients with lupus erythematosus in a sample of the Egyptian population: a hospital based cross-sectional study.
    Saeed HM; Mohammad Amr E; Rezk Lotfy Rezk A; Abd Elmoneim W
    F1000Res; 2021; 10():969. PubMed ID: 35707453
    [No Abstract]   [Full Text] [Related]  

  • 28. Uncommon toxic epidermal necrolysis -like presentation of cutaneous lupus erythematosus: A series of 6 cases.
    Rajagopal V; Bains A; Kannan K; Bhardwaj A; Elhence P
    Lupus; 2024 May; ():9612033241255266. PubMed ID: 38745410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19.
    Souza EN; Diniz LM; Moura LAD; Oliosi AC
    Actas Dermosifiliogr; 2024 Apr; 115(4):T430-T432. PubMed ID: 38325543
    [No Abstract]   [Full Text] [Related]  

  • 30. Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19.
    Souza EN; Diniz LM; Moura LAD; Oliosi AC
    Actas Dermosifiliogr; 2024 Apr; 115(4):430-432. PubMed ID: 36511288
    [No Abstract]   [Full Text] [Related]  

  • 31. Dermatological Manifestation of SLE Patients, Living in Aseer Region.
    Alhammadi NA; Alqahtani H; Al Hamdan SA; Al Hamdan JA; Hadhir Alalyani RT; Asiri SAA; Alqahtani RS; Aljari AAM; Asiri GBM
    J Family Med Prim Care; 2024 Apr; 13(4):1249-1253. PubMed ID: 38827701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous Manifestations of "Lupus": Systemic Lupus Erythematosus and Beyond.
    Cooper EE; Pisano CE; Shapiro SC
    Int J Rheumatol; 2021; 2021():6610509. PubMed ID: 34113383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A destructive nasal skin lesion caused by fungal infection in a systemic lupus erythematosus patient.
    de Campos MR; Della FCP; Solórzano CLV; Ramos SE; Piovesan DM; da Silva BM; Ritter CG; Bredemeier M
    Clin Rheumatol; 2023 May; 42(5):1487-1489. PubMed ID: 36800136
    [No Abstract]   [Full Text] [Related]  

  • 34. Extensive hypertrophic lupus erythematosus: atypical presentation.
    Narang T; Sharma M; Gulati N; Kaur A
    Indian J Dermatol; 2012 Nov; 57(6):504. PubMed ID: 23248382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [LABORATORY DIAGNOSIS OF DISSEMINATED LUPUS ERYTHRMATOSUS].
    DENISOVA MG
    Lab Delo; 1965; 1():9-10. PubMed ID: 14348322
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral lupus erythematosus: Immunohistochemical evaluation of CD1a, CD21, CD123, and langerin expression in dendritic cells.
    Marques ERMDC; Hsieh R; Lourenço SV; Nico MMS
    J Cutan Pathol; 2024 May; 51(5):368-378. PubMed ID: 38287771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement-4 deficiency in a child with systemic lupus erythematosus presenting with standard treatment-resistant severe skin lesion.
    Sozeri B; Mir S; Berdeli A
    ISRN Rheumatol; 2011; 2011():917673. PubMed ID: 22482068
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.